MedTrace Logo

Post-Market Registry Of Stroke Patients Treated With Medtronic Neuro Thrombectomy Devices to Collect Real World Data in South East Asia

NCT03364023 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 183

Last updated 2020-08-19

Study results available
· View outcomes & findings →

Summary

The purpose of this post-market registry is to collect real-world data associated with the use of Medtronic market-released neurothrombectomy devices in acute ischemic stroke (AIS) patients from countries in South East Asia.

Conditions

  • Stroke, Acute

Interventions

DEVICE

Neurothrombectomy

Medtronic Market-Released Neurothrombectomy Device

Sponsors & Collaborators

  • Medtronic Neurovascular Clinical Affairs

    lead INDUSTRY

Principal Investigators

  • Ka Sing Lawrence Wong, MD · Chinese University of Hong Kong

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-07-02
Completion
2019-07-02
FDA Device
Yes

Countries

  • Singapore
  • Thailand
  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03364023 on ClinicalTrials.gov